100% tevredenheidsgarantie Direct beschikbaar na je betaling Lees online óf als PDF Geen vaste maandelijkse kosten
logo-home
Eerder door jou gezocht
Eerder door jou gezocht
logo
Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections €6,03
In winkelwagen
Snel navigeren naar
Voorbeeld
  2.  
  3. Pharmacotherapeutics
  4.  
  5. Pharmacotherapeutics

Tentamen (uitwerkingen)

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections
 1 keer verkocht
  • Vak
  • Pharmacotherapeutics
  • Instelling
  • Pharmacotherapeutics

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections

Voorbeeld 2 van de 5  pagina's

Document informatie

  • 2 mei 2022
  • 5
  • 2021/2022
  • Tentamen (uitwerkingen)
  • Vragen en antwoorden

Onderwerpen

  • fungal
  • and protozoal infections
  • pharmacotherapeutics for advanced practice nurse prescribers 5th edition woo robinson test bank chapter 24 drugs used to treat viral

Geschreven voor

  • Pharmacotherapeutics
Alle documenten voor dit vak (381)

Verkoper

avatar-seller
IANWAZASKISTUVIA

Ontvangen beoordelingen

Voorbeeld van de inhoud

Pharmacotherapeutics for Advanced
Practice Nurse Prescribers 5th Edition Woo
Robinson Test Bank


Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections
MULTIPLE CHOICE
1. Which person should be treated with prophylactic antitubercular medication?
a. A child who attends the same school with a child who has tuberculosis
b. A nurse who is working in a hospital
c. An individual who is HIV-positive with a negative TB skin test
d. A patient who has close contact with someone who has tuberculosis
ANS: D
Personal contact with a person having a diagnosis of tuberculosis is required to indicate prophylactic treatment
with antitubercular therapy. Attending the same school does not necessarily mean close contact occurs. Health
care professionals do not need prophylactic treatment. HIV-positive individuals with negative TB skin tests do not
need prophylaxis.
2. A patient who has chronic liver disease reports contact with a person who has tuberculosis (TB). The nurse
will counsel this patient to contact the provider to discuss a. a chest x-ray.
b. a TB skin test.
c. liver function tests (LFTs).
d. prophylactic antitubercular drugs. ANS: B
Patients who have exposure to TB should have a TB skin test. A chest x-ray is performed if the skin test is
positive. LFTs do not need to be done simply because of TB exposure. This patient is not a candidate for
antitubercular drug prophylaxis.
3. A patient who has tuberculosis asks the nurse why three drugs are used to treat this disease. The nurse will
explain that multi-drug therapy is used to reduce the likelihood of a. disease relapse.
b. drug hypersensitivity reactions.
c. drug resistance.
d. drug adverse effects. ANS: C
Without multi-drug therapy, patients easily develop resistance to antitubercular drugs. Using more than one
antitubercular drug does not prevent relapse, hypersensitivity reactions, or adverse effects.
4. A patient is being treated with isoniazid (INH), rifampin, and pyrazinamide in phase I of treatment for
tuberculosis. The organism develops resistance to isoniazid. Which drug will the nurse anticipate the provider will
order to replace the isoniazid? a. Ciprofloxacin (Cipro)
b. Ethambutol (Myambutol)

, c. Kanamycin
d. Streptomycin sulfate ANS: B
If there is bacterial resistance to isoniazid, the first phase may be changed to ethambutol, rifampin, and
pyrazinamide. Ciprofloxacin, kanamycin, and streptomycin are not generally first-line antitubercular drugs.
5. The nurse is caring for a patient who is diagnosed with tuberculosis. The patient tells the nurse that the provider
plans to order a prophylactic antitubercular drug for family members and asks which drug will be ordered. The
nurse will expect the provider to order which drug? a. Isoniazid (INH)
b. Pyrazinamide
c. Rifampin (Rifadin)
d. Streptomycin ANS: A
INH is the drug of choice for prophylactic treatment of patients who have had close contact with a patient who has
tuberculosis.
6. The nurse caring for a patient who has tuberculosis and who is taking isoniazid, rifampin, and streptomycin
reviews the medical record and notes the patients sputum cultures reveal resistance to streptomycin. The nurse
will anticipate that the provider will take which action? a. Add ethambutol (Myambutol).
b. Change the streptomycin to clarithromycin.
c. Change the streptomycin to kanamycin.
d. Order renal function tests. ANS: C
The patients current regimen is first-phase treatment. If resistance to streptomycin develops, the provider can
change to kanamycin or to ciprofloxacin. Ethambutol is added if there is resistance to isoniazid. Clarithromycin is
used during phase II. Renal function tests are not indicated.
7. A patient who is taking isoniazid (INH) as part of a two-drug tuberculosis treatment regimen reports tingling of
the fingers and toes. The nurse will recommend discussing which treatment with the provider? a. Adding
pyrazinamide
b. Changing to ethambutol
c. Increasing oral fluid intake
d. Taking pyridoxine (B6) ANS: D
Peripheral neuropathy is an adverse reaction to INH, so pyridoxine is usually given to prevent this. It is not
necessary to change medications. Increasing fluids will not help with this.
8. The nurse is teaching a patient about rifampin. Which statement by the patient indicates understanding of the
teaching?
a. I should not wear soft contact lenses while taking rifampin.
b. I will need regular eye examinations while taking this drug.
c. I will report orange urine to my provider immediately.
d. I understand that renal toxicity is a common adverse effect.
ANS: A
Patients taking rifampin should be warned that urine, feces, saliva, sputum, sweat, and tears may turn a harmless
red-orange color. Patients should not wear soft contact lenses to avoid permanent staining. Regular eye exams are
necessary for patients who receive isoniazid and ethambutol. Orange urine is a harmless side effect and does not
need to be reported. Renal toxicity is not common with rifampin.
9. A patient who has completed the first phase of a three-drug regimen for tuberculosis has a positive sputum acid-
bacilli test. The nurse will tell the patient that a. drug resistance has probably occurred.

Dit zijn jouw voordelen als je samenvattingen koopt bij Stuvia:

Bewezen kwaliteit door reviews

Bewezen kwaliteit door reviews

Studenten hebben al meer dan 850.000 samenvattingen beoordeeld. Zo weet jij zeker dat je de beste keuze maakt!

In een paar klikken geregeld

In een paar klikken geregeld

Geen gedoe — betaal gewoon eenmalig met iDeal, creditcard of je Stuvia-tegoed en je bent klaar. Geen abonnement nodig.

Direct to-the-point

Direct to-the-point

Studenten maken samenvattingen voor studenten. Dat betekent: actuele inhoud waar jij écht wat aan hebt. Geen overbodige details!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper IANWAZASKISTUVIA. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor €6,03. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 69052 samenvattingen verkocht

Opgericht in 2010, al 15 jaar dé plek om samenvattingen te kopen

Begin nu gratis
€6,03  1x  verkocht
  • (0)
In winkelwagen
Toegevoegd